Filing Details

Accession Number:
0001209191-20-058819
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-17 17:30:08
Reporting Period:
2020-11-13
Accepted Time:
2020-11-17 17:30:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1751757 Roy Winston C/O Pacira Biosciences, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Chief Clinical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-13 5,000 $62.00 34,785 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Includes 548 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020.